02170.HK
Suzhou Basecare Medical Corporation Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 1.38
−2.82%Year over year
Reported trailing growth
- Revenue
- -5.5%
- EBITDA
- +56.1%
- EBIT
- +27.1%
- EPS
- +25.6%
- Free cash flow
- +66.1%
- Operating cash flow
- +67.6%
Forward estimates
Based on analyst estimates
- Revenue
- -23.5%
- EBITDA
- -88.9%
- EPS
- -23.0%
Three-year CAGR
- Revenue
- +18.3%
- EBITDA
- +34.1%
- EBIT
- +7.3%
- Net income
- +5.7%
- EPS
- +5.7%
- Free cash flow
- +24.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026